Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA Therapies

Thursday, July 07, 2022

BeiGene a global sciencedriven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide today announced it entered into a worldwide strategic collaboration with In...

AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening haematological cancer pipeline

Wednesday, July 06, 2022

AstraZeneca today announced an agreement to acquire TeneoTwo Inc TeneoTwoi including its Phase I clinicalstage CDCD Tcell engager TNB currently under evaluation in relapsed and refractory Bcell nonHodgkin lymphoma The acquisition of TNB aims to accel...

Evotec completes acquisition of Rigenerand

Wednesday, July 06, 2022

Evotec SE announced that the strategic transaction to acquire Rigenerand Srl signed in May has been completed Based out of Medolla Italy the cell technology company with leading edge in the field of cGMP manufacturing of cell therapies will operate...

ProteoNic Announces Licensing of its Premium 2G UNic™ Technology Platform for Production of Biologics to FyoniBio

Tuesday, July 05, 2022

ProteoNic BV a leading provider of premium vector technology and services for efficient production of biologics and FyoniBio GmbH a contract development organization for biopharmaceuticals today announced they have entered into a technology licensing...

Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH)

Tuesday, July 05, 2022

Lonza a global development and manufacturing partner to the pharma biotech and nutrition industries today announced plans to construct a largescale commercial drug product fill and finish facility in Stein CH The investment will enable the company to...

Vaxart Announces Agreement with hVIVO to Develop World’s First Human Omicron Challenge Model

Friday, July 01, 2022

Vaxart Inc announced an agreement with hVIVO Services Limited a subsidiary of Open Orphan plc under which hVIVO will conduct a characterization study and if successful develop a human challenge model based on the Omicron variant of SARSCoV with the i...

Phanes Therapeutics’ PT886 granted Orphan Drug Designation for the treatment of pancreatic cancer by the FDA

Friday, July 01, 2022

Phanes Therapeutics Inc an emerging leader in innovative discovery research and clinical development in oncology announced today that the US Food and Drug Administration FDA has granted orphan drug designation to PT for the treatment of pancreatic ca...

Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine

Thursday, June 30, 2022

Pfizer Inc and BioNTech SE announced a new vaccine supply agreement with the US government to support the continued fight against COVID Under the agreement the US government will receive million doses g g and g This may include adult Omicronadapt...

Generian and Astellas Enter into Collaboration and Exclusive License Agreement to Discover and Develop Novel Small Molecules For Undruggable Targets

Thursday, June 30, 2022

Generian Pharmaceuticals Inc and Mitobridge Inc announced today that they have entered into a collaboration and exclusive license agreement to discover and develop novel small molecules for undruggable therapeutic targets by using a proprietary drug...

Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic

Wednesday, June 29, 2022

Akoya Biosciences Inc The Spatial Biology Company and Acrivon Therapeutics Inc a clinicalstage oncology therapeutics company with proprietary technologies driving a new era of precisionbased medicine today announced an agreement to codevelop validate...